Fiera Capital (Canada)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.5M Sell
246,062
-4,725
-2% -$1.05M 0.18% 93
2025
Q4
$57.3M Buy
250,787
+86,170
+52% +$19.6M 0.18% 104
2025
Q3
$38.1M Buy
164,617
+55,807
+51% +$11.4M 0.12% 122
2025
Q2
$20.2M Buy
108,810
+27,419
+34% +$5.1M 0.07% 154
2025
Q1
$17.1M Buy
81,391
+10,758
+15% +$2.09M 0.06% 164
2024
Q4
$12.6M Buy
70,633
+11,005
+18% +$2.02M 0.04% 170
2024
Q3
$11.8M Buy
59,628
+3,441
+6% +$642K 0.04% 175
2024
Q2
$9.64M Buy
56,187
+53,112
+1,727% +$8.8M 0.03% 168
2024
Q1
$560K Sell
3,075
-215
-7% -$37.1K ﹤0.01% 390
2023
Q4
$510K Sell
3,290
-200
-6% -$29.2K ﹤0.01% 443
2023
Q3
$520K Buy
3,490
+90
+3% +$13.2K ﹤0.01% 420
2023
Q2
$458K Buy
+3,400
New +$499K ﹤0.01% 437
2022
Q4
Sell
-14,706
Closed -$1.97M 506
2022
Q3
$1.97M Buy
14,706
+11,027
+300% +$1.58M 0.01% 295
2022
Q2
$563K Sell
3,679
-12,800
-78% -$1.96M ﹤0.01% 488
2022
Q1
$2.67M Buy
16,479
+10,628
+182% +$1.54M 0.01% 287
2021
Q4
$792K Buy
5,851
+479
+9% +$56.6K ﹤0.01% 449
2021
Q3
$579K Sell
5,372
-13,431
-71% -$1.53M ﹤0.01% 440
2021
Q2
$2.12M Buy
+18,803
New +$2.12M 0.01% 288
2021
Q1
Sell
-27,074
Closed -$2.9M 572
2020
Q4
$2.9M Buy
27,074
+25
+0.1% +$2.4K 0.01% 308
2020
Q3
$2.37M Sell
27,049
-11,476
-30% -$1.08M 0.01% 304
2020
Q2
$3.78M Sell
38,525
-196
-0.5% -$17.3K 0.01% 251
2020
Q1
$2.95M Sell
38,721
-3,172
-8% -$270K 0.01% 263
2019
Q4
$3.71M Buy
41,893
+534
+1% +$44.3K 0.01% 268
2019
Q3
$3.13M Sell
41,359
-295
-0.7% -$20.2K 0.01% 286
2019
Q2
$3.03M Sell
41,654
-1,090
-3% -$85.7K 0.01% 318
2019
Q1
$3.44M Sell
42,744
-225,193
-84% -$18.4M 0.01% 303
2018
Q4
$24.7M Sell
267,937
-4,356
-2% -$383K 0.11% 146
2018
Q3
$25.8M Sell
272,293
-3,702
-1% -$351K 0.1% 164
2018
Q2
$25.6M Buy
275,995
+5,449
+2% +$532K 0.11% 155
2018
Q1
$25.6M Buy
270,546
+2,410
+0.9% +$265K 0.12% 143
2017
Q4
$25.9M Sell
268,136
-9,435
-3% -$889K 0.12% 153
2017
Q3
$24.7M Sell
277,571
-8,600
-3% -$655K 0.12% 158
2017
Q2
$20.8M Sell
286,171
-71,939
-20% -$4.84M 0.1% 171
2017
Q1
$23.3M Sell
358,110
-16,387
-4% -$1.03M 0.12% 167
2016
Q4
$23.5M Sell
374,497
-86,267
-19% -$5.27M 0.13% 163
2016
Q3
$29.1M Sell
460,764
-24,207
-5% -$1.57M 0.16% 150
2016
Q2
$30M Sell
484,971
-73,974
-13% -$4.51M 0.17% 151
2016
Q1
$31.9M Sell
558,945
-161,502
-22% -$9M 0.23% 89
2015
Q4
$42.7M Buy
720,447
+37,783
+6% +$2.18M 0.33% 73
2015
Q3
$37.1M Sell
682,664
-40,780
-6% -$2.65M 0.31% 79
2015
Q2
$48.6K Buy
723,444
+76,396
+12% +$4.99M 0.3% 76
2015
Q1
$37.9M Sell
647,048
-19,690
-3% -$1.19M 0.28% 83
2014
Q4
$43.6M Buy
666,738
+29,724
+5% +$1.87M 0.32% 79
2014
Q3
$36.8M Buy
637,014
+93,331
+17% +$5.18M 0.27% 86
2014
Q2
$30.7M Buy
543,683
+124,798
+30% +$6.55M 0.16% 109
2014
Q1
$21.5M Buy
418,885
+18,691
+5% +$945K 0.16% 125
2013
Q4
$21.1M Buy
400,194
+361,594
+937% +$17.8M 0.17% 117
2013
Q3
$1.73M Buy
38,600
+600
+2% +$26.6K 0.02% 248
2013
Q2
$1.57M Buy
+38,000
New +$1.66M 0.02% 249

Other funds holding ABBV

Fiera Capital (Canada)'s ABBV Position: Q1 2026 in Review

Fiera Capital (Canada) reduced its AbbVie (ABBV) stake by 1.9% in Q1 2026, selling an estimated $1.05M and leaving 246,062 shares worth $53.5M. The position accounts for 0.18% of the portfolio, ranked #93.

Fiera Capital (Canada) first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $57.3M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Fiera Capital (Canada) held 246,062 shares of AbbVie worth $53.5M as of Q1 2026.
  • Fiera Capital (Canada) sold 4,725 AbbVie shares in Q1 2026, an estimated $1.05M.
  • AbbVie made up 0.18% of Fiera Capital (Canada)'s portfolio in Q1 2026, its #93 holding.
  • Fiera Capital (Canada) first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
  • Fiera Capital (Canada)'s AbbVie position peaked at $57.3M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2026, filed 12 May 2026.